Mr. Speaker, I am pleased to hear my colleague across talking about his care for family and friends. I share that, of course, in my own riding of Essex.
I am deeply concerned for my riding of Essex and his riding of Oakville as a result of the impacts of increased costs of prescription drugs for Canadians. I cannot understand how the member opposite will explain this to the many people of Oakville. I have many friends who live in Oakville and who work in Oakville, and they do not support increased drugs costs in a trade deal like we see in CETA.
Increasing drug costs for Canadians, changing our patent legislation—25% of CETA implementing legislation are changes to the Patent Act—have absolutely no place in a trade agreement in 2016. This would hurt Canadians. I cannot comprehend how, in a working community like Oakville, where the member across is from, he can explain to everyone there that he will now sign a trade agreement and stand proudly and happily to saddle them with increased drug costs from the moment that we sign on and from the moment that the member votes going forward.
I would like an explanation on how he will explain the increased drug costs to the people of his riding of Oakville.